Free Trial
LON:THRL

Target Healthcare REIT (THRL) Share Price, News & Analysis

Target Healthcare REIT logo
GBX 96.20 +0.10 (+0.10%)
As of 08/28/2025 11:50 AM Eastern

About Target Healthcare REIT Stock (LON:THRL)

Key Stats

Today's Range
95.10
96.70
50-Day Range
95.43
105
52-Week Range
78.77
107
Volume
726,430 shs
Average Volume
2.03 million shs
Market Capitalization
£588.85 million
P/E Ratio
8.06
Dividend Yield
6.24%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive THRL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Target Healthcare REIT and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THRL Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
See More Headlines

THRL Stock Analysis - Frequently Asked Questions

Target Healthcare REIT's stock was trading at GBX 83.99 at the start of the year. Since then, THRL shares have increased by 14.5% and is now trading at GBX 96.20.

Target Healthcare REIT (LON:THRL) announced its quarterly earnings data on Friday, March, 14th. The company reported $3.06 earnings per share (EPS) for the quarter. Target Healthcare REIT had a trailing twelve-month return on equity of 10.78% and a net margin of 104.99%.
Read the conference call transcript
.

Shares of THRL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Target Healthcare REIT investors own include Realty Income (O), AT&T (T), Cambian Group (CMBN), Meta Platforms (META), Pfizer (PFE), Primary Health Properties (PHP) and Aviva (AV).

Company Calendar

Last Earnings
3/14/2025
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
REIT - Healthcare Facilities
Sub-Industry
N/A
Current Symbol
LON:THRL
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 11.93
Trailing P/E Ratio
8.06
Forward P/E Ratio
15.46
P/E Growth
1.48
Net Income
£72.07 million
Net Margins
104.99%
Pretax Margin
N/A
Return on Equity
10.78%
Return on Assets
3.86%

Debt

Debt-to-Equity Ratio
34.92
Current Ratio
7.20
Quick Ratio
1.52

Sales & Book Value

Annual Sales
£68.64 million
Price / Sales
8.58
Cash Flow
GBX 6.70 per share
Price / Cash Flow
14.37
Book Value
GBX 111.13 per share
Price / Book
0.87

Miscellaneous

Outstanding Shares
612,105,168
Free Float
N/A
Market Cap
£588.85 million
Optionable
Not Optionable
Beta
0.44
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (LON:THRL) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners